Loading
Breast surgeon and ESSO Past-President who heads breast surgical oncology at Clínica Universidad de Navarra in Madrid.
Isabel-Teresa Rubio is Past-President of ESSO and Head of Breast Surgical Oncology at Clínica Universidad de Navarra, Madrid. Her work focuses on axillary management, de-escalation of breast surgery and oncoplastic techniques, and she has led European efforts to define breast surgical oncology training and certification.
| Title | Journal | Year |
|---|---|---|
| European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO | European Journal of Surgical Oncology | 2024 |
| Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey | European Journal of Surgical Oncology | 2019 |
| Global Forum of Cancer Surgeons: Cancer Surgery During the COVID-19 Pandemic: Impact and Lessons Learned | Annals of Surgical Oncology | 2022 |
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, surgical oncology.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist, surgical oncology.